Plus Therapeutics Announces Patient-Focused Presentation Supporting Brain Tumor Awareness Month

    NEXT STORY
    Vyriad Inc. Announces Development of a New Antibody Test to Determine Protective Immunity From COVID-19
    PREV STORY
    Montreal Heart Institute Colcorona Study receives grant from the COVID-19 Therapeutics Accelerator via the Bill & Melinda Gates Foundation to investigate cheap, readily available drug
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Sanofi Q3 well on track

    author_avatar
    NASDAQ Market News

    Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

    BOSTON, Sept. 01, 2017 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company ...

    author_avatar
    NASDAQ Market News

    Athenex Announces FDA Acceptance for Filing of U.S. NDA for Oral Paclitaxel and Encequidar in Metastatic Breast Cancer with Priority Review

    author_avatar
    NASDAQ Market News